Health Canada to Disclose Plan for Regulating Chemotherapy Drug Oversight

This article was last updated on April 16, 2022

Canada: Free $30 Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
USA: Free $30 Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…

Health Canada has scheduled to disclose a plan today for covering a sensitive gap of oversight which resulted in more than 1,200 cancer patients receiving diluted chemotherapy drugs. Anonymous sources close to the federal health minister’s office explained that government executives from all over the country are expected to take part in a national conference call today which is aimed to ensure some level of government supervision on companies supplying large volumes of mixed drugs to hospitals.

The policy is being brought to light due to last week’s revelation of a Mississauga company, contracted to supply hospitals in Ontario and New Brunswick, which accidently mixed up an inaccurate, diluted dosage of intravenous cancer drugs. Later, it was exposed that the company was operating without any sort of oversight from either provincial or federal inspectors. The source explained that the conference call will include deputy health ministers from each province and territory, for whom “there will be a proposal put forward.” It was explained that “they will either adopt the proposal and agree to it or they will not. We’ll see how the co-operative, everyone-doing-their-part thing goes tomorrow.”

The spokesperson for the Health Ministry in British Columbia and Ontario alleged that they were looking forward to the discussion. In an email, the spokeswoman for Ontario Health Minister Deb Matthews, Zita Astravas, mentioned that “…we hope that as part of their solution, the federal government will choose to exercise the extensive powers they already … have under the Food and Drug Act to take action and resolve the current issue.”

Share with friends
You can publish this article on your website as long as you provide a link back to this page.

Be the first to comment

Leave a Reply

Your email address will not be published.


*